Advanced search
1 file | 415.29 KB Add to list

Non-linear mixed effect modeling of the time-variant disposition of erythropoietin in anemic cancer patients

Author
Organization
Keywords
time-variant pharmacokinetics, simplistic pharmacokinetic model, RECOMBINANT-HUMAN-ERYTHROPOIETIN, CHEMOTHERAPY-INDUCED ANEMIA, PLACEBO-CONTROLLED TRIAL, QUALITY-OF-LIFE, EPOETIN-ALPHA, DARBEPOETIN-ALPHA, HEALTHY-SUBJECTS, DOUBLE-BLIND, POPULATION PHARMACOKINETICS, NONPLATINUM CHEMOTHERAPY, chemotherapy-induced anemia, recombinant human erythropoietin

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 415.29 KB

Citation

Please use this url to cite or link to this publication:

MLA
Ait-Oudhia, Sihem, An Vermeulen, and Wojciech Krzyzanski. “Non-linear Mixed Effect Modeling of the Time-variant Disposition of Erythropoietin in Anemic Cancer Patients.” BIOPHARMACEUTICS & DRUG DISPOSITION 32.1 (2011): 1–15. Print.
APA
Ait-Oudhia, S., Vermeulen, A., & Krzyzanski, W. (2011). Non-linear mixed effect modeling of the time-variant disposition of erythropoietin in anemic cancer patients. BIOPHARMACEUTICS & DRUG DISPOSITION, 32(1), 1–15.
Chicago author-date
Ait-Oudhia, Sihem, An Vermeulen, and Wojciech Krzyzanski. 2011. “Non-linear Mixed Effect Modeling of the Time-variant Disposition of Erythropoietin in Anemic Cancer Patients.” Biopharmaceutics & Drug Disposition 32 (1): 1–15.
Chicago author-date (all authors)
Ait-Oudhia, Sihem, An Vermeulen, and Wojciech Krzyzanski. 2011. “Non-linear Mixed Effect Modeling of the Time-variant Disposition of Erythropoietin in Anemic Cancer Patients.” Biopharmaceutics & Drug Disposition 32 (1): 1–15.
Vancouver
1.
Ait-Oudhia S, Vermeulen A, Krzyzanski W. Non-linear mixed effect modeling of the time-variant disposition of erythropoietin in anemic cancer patients. BIOPHARMACEUTICS & DRUG DISPOSITION. 2011;32(1):1–15.
IEEE
[1]
S. Ait-Oudhia, A. Vermeulen, and W. Krzyzanski, “Non-linear mixed effect modeling of the time-variant disposition of erythropoietin in anemic cancer patients,” BIOPHARMACEUTICS & DRUG DISPOSITION, vol. 32, no. 1, pp. 1–15, 2011.
@article{4325452,
  author       = {Ait-Oudhia, Sihem and Vermeulen, An and Krzyzanski, Wojciech},
  issn         = {0142-2782},
  journal      = {BIOPHARMACEUTICS & DRUG DISPOSITION},
  keywords     = {time-variant pharmacokinetics,simplistic pharmacokinetic model,RECOMBINANT-HUMAN-ERYTHROPOIETIN,CHEMOTHERAPY-INDUCED ANEMIA,PLACEBO-CONTROLLED TRIAL,QUALITY-OF-LIFE,EPOETIN-ALPHA,DARBEPOETIN-ALPHA,HEALTHY-SUBJECTS,DOUBLE-BLIND,POPULATION PHARMACOKINETICS,NONPLATINUM CHEMOTHERAPY,chemotherapy-induced anemia,recombinant human erythropoietin},
  language     = {eng},
  number       = {1},
  pages        = {1--15},
  title        = {Non-linear mixed effect modeling of the time-variant disposition of erythropoietin in anemic cancer patients},
  url          = {http://dx.doi.org/10.1002/bdd.733},
  volume       = {32},
  year         = {2011},
}

Altmetric
View in Altmetric
Web of Science
Times cited: